AIP
CL icon

Almanack Investment Partners’s Colgate-Palmolive CL Stock Holding History

Almanack Investment Partners’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-159
Closed -$11K – 360
2022
Q3 		$11K Buy
+159
New +$12.5K ﹤0.01% 459

Other funds holding CL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
TP
Third Point New York $2.08B AUM 27.04% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Almanack Investment Partners's CL Position: Q4 2022 in Review

Almanack Investment Partners sold out of Colgate-Palmolive (CL) in Q4 2022, closing a stake of 159 shares — an estimated $11K sold.

Almanack Investment Partners first reported a position in CL in Q3 2022 and held it in 1 quarter. The position peaked at $11K in Q3 2022. 1,698 funds tracked by Wall St. Rank hold CL as of Q4 2022.

  • Almanack Investment Partners reported no remaining Colgate-Palmolive position as of Q4 2022 after selling out during the quarter.
  • Almanack Investment Partners sold 159 Colgate-Palmolive shares in Q4 2022, an estimated $11K.
  • Almanack Investment Partners first reported a position in Colgate-Palmolive in Q3 2022 and held it in 1 quarter.
  • Almanack Investment Partners's Colgate-Palmolive position peaked at $11K in Q3 2022.
  • 1,698 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q4 2022.

Based on Almanack Investment Partners's 13F filing for Q4 2022, filed 9 Feb 2023.